Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Demirer

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|September 9, 2004
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluationT Demirer, M Ayli, T Fen, et al.
Blood|March 15, 1995
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factorW I Bensinger, C H Weaver, F R Appelbaum, et al.
Bone Marrow Transplantation|March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Factors that influence collection and engraftment of autologous peripheral-blood stem cellsW Bensinger, F Appelbaum, S Rowley, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999
Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case reportC Ustün, H Celebi, M Arat, et al.
Bone Marrow Transplantation|July 24, 2008
28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 proceduresR Ladenstein, U Pötschger, O Hartman, et al.
Bone Marrow Transplantation|August 28, 2003
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999P Pedrazzoli, P Ferrante, A Kulekci, et al.
Bone Marrow Transplantation|June 1, 1996
Factors influencing collection of peripheral blood stem cells in patients with multiple myelomaT Demirer, C D Buckner, T Gooley, et al.
Bone Marrow Transplantation|May 1, 1996
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancerT Demirer, C D Buckner, F R Appelbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experienceU De Giorgi, T Demirer, H Wandt, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|September 9, 2004
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluationT Demirer, M Ayli, T Fen, et al.
Blood|March 15, 1995
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factorW I Bensinger, C H Weaver, F R Appelbaum, et al.
Bone Marrow Transplantation|March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Factors that influence collection and engraftment of autologous peripheral-blood stem cellsW Bensinger, F Appelbaum, S Rowley, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999
Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case reportC Ustün, H Celebi, M Arat, et al.
Bone Marrow Transplantation|July 24, 2008
28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 proceduresR Ladenstein, U Pötschger, O Hartman, et al.
Bone Marrow Transplantation|August 28, 2003
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999P Pedrazzoli, P Ferrante, A Kulekci, et al.
Bone Marrow Transplantation|June 1, 1996
Factors influencing collection of peripheral blood stem cells in patients with multiple myelomaT Demirer, C D Buckner, T Gooley, et al.
Bone Marrow Transplantation|May 1, 1996
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancerT Demirer, C D Buckner, F R Appelbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experienceU De Giorgi, T Demirer, H Wandt, et al.
Pageof 7